Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Revenue: 2016-2024

Historic Revenue for Dianthus Therapeutics (DNTH) over the last 4 years, with Dec 2024 value amounting to $6.2 million.

  • Dianthus Therapeutics' Revenue fell 81.77% to $396,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 42.31%. This contributed to the annual value of $6.2 million for FY2024, which is 120.63% up from last year.
  • According to the latest figures from FY2024, Dianthus Therapeutics' Revenue is $6.2 million, which was up 120.63% from $2.8 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Revenue ranged from a high of $6.4 million in FY2022 and a low of $2.8 million during FY2023.
  • Over the past 3 years, Dianthus Therapeutics' median Revenue value was $6.2 million (recorded in 2024), while the average stood at $5.2 million.
  • In the last 5 years, Dianthus Therapeutics' Revenue slumped by 55.96% in 2023 and then spiked by 120.63% in 2024.
  • Over the past 3 years, Dianthus Therapeutics' Revenue (Yearly) stood at $6.4 million in 2022, then slumped by 55.96% to $2.8 million in 2023, then soared by 120.63% to $6.2 million in 2024.